ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via ISI Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Melloni, B.
Right arrow Articles by Bonnaud, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Melloni, B.
Right arrow Articles by Bonnaud, F.
Eur Respir J 2004; 24:814-821
Copyright ©ERS Journals Ltd 2004

Assessment of 18F-fluorodeoxyglucose dual-head gamma camera in asbestos lung diseases

B. Melloni1, J. Monteil2, F. Vincent1, F. Bertin3, S. Gaillard4, T. Ducloux2, S. Verbeke2, A. Maubon4, J-C. Vandroux2 and F. Bonnaud1

Depts of 1 Pneumology, 2 Nuclear Medicine, 3 Thoracic and Cardiovascular Surgery, and 4 Radiology, Centre Hospitalier et Universitaire de Limoges, Limoges, France.

CORRESPONDENCE: B. Melloni, Service de Pathologie Respiratoire, Hôpital du Cluzeau, CHU Limoges, 23 avenue Dominique Larrey, 87042 Limoges, France. Fax: 33 555056683. E-mail: melloni@unilim.fr

Keywords: Asbestos, 18F-fluorodeoxyglucose, gamma camera coincidence imaging, malignant mesothelioma

Received: January 13, 2004
Accepted June 21, 2004

The purpose of this study was to evaluate the performance of 18F-fluorodeoxyglucose (18FDG) imaging via coincidence detection emission tomography (CDET) in identifying malignant lesions in subjects exposed to asbestos.

A total of 30 patients exposed to asbestos underwent 18FDG-CDET between January 2000 and June 2003. A CDET scan of the thorax and abdomen was performed 60 min after injection of 18FDG in fasting patients, and results were obtained in slices in three axes. The CDET results were compared to those from computed tomography (CT), and pleural or surgical biopsy in patients with positive 18FDG-CDET results.

All primary malignant mesotheliomas accumulated 18FDG (n=6), and, in two patients, CDET findings were superior to those of CT, allowing early detection. In two cases, lung carcinomas with malignant pleural effusion were also detected. There were five false positive CDET results: three unilateral pleural thickening, one rounded atelectasis, and one benign lung nodule. All patients with pleural plaques showed no significant 18FDG uptake. Malignant diseases were detected by 18FDG-CDET imaging with a sensitivity of 89% and specificity of 71%.

Coincidence detection emission tomography can identify malignant mesothelioma in selected subjects exposed to asbestos. Coincidence detection emission tomography appears to be a useful noninvasive method for the follow-up of subjects with exposure risk of asbestosis.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the European Respiratory Society.